6.79 USD
↘ 0.11 (1.59%)AT CLOSE (11:59 AM EDT)
Quoin Pharmaceuticals, Ltd. American Depositary Shares
QNRXNASDAQ • USD
6.85
↗ 0.06 (0.88%)
POST MARKET (AS OF 05:08 PM EDT)
Post Market
AS OF 05:08 PM EDT
6.85
↗ 0.06 (0.88%)
Market: CLOSED
QNRX is currently priced at $6.79. QNRX shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place QNRX at a fair price relative to peers.
Technical & fundamental data as of Sep 11, 2026.
Open?$6.87
High?$6.87
Low?$6.66
Prev. Close?$6.90
Volume?65.7K
Avg. Volume?1.1M
VWAP?$6.78
Rel. Volume?0.06x
Bid / Ask
Bid?$6.61 × 100
Ask?$7.14 × 100
Spread?$0.53
Midpoint?$6.88
Valuation & Ratios
Market Cap?13.6M
Shares Out?2.0M
P/E Ratio?N/A
P/B Ratio?3.47
EPS?-$9.29
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Employees
6
Market Cap
13.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-28
Address
23 HATA'AS STREET
KFAR SABA, 44425
Phone: 97299741444
KFAR SABA, 44425
Phone: 97299741444
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?43
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.27Distress
Confidence?57%Low
Short InterestLow
Short Interest?526.7K
Days to Cover?1.0
Avg Daily Volume2.8M
Settlement Date2026-08-31
Financial Health
Current Ratio?1.76Adequate
Quick Ratio?1.76Adequate
Cash Ratio?0.58Adequate
Debt/Equity?0.29Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.47FAIR▾
Peers100
S&P49
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-474.6%WEAK▾
S&P3
ROA?-155.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15273747
Enterprise Value?$10.9M
Fundamentals ratios updated end of day